Renee P Tannenbaum Ani Pharmaceuticals Inc (ANIP) insider trading activity

Renee P Tannenbaum is Director of ANI PHARMACEUTICALS INC. Currently has a direct ownership of 26,957 shares of ANIP, which is worth approximately $1.61 Million. The most recent transaction as insider was on May 22, 2025, when has been sold 4,336 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27K

19.17% 3M change

19.17% 12M change

Total Value Held $1.61 Million

RENEE P TANNENBAUM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 22 2025	BUY Grant, award, or other acquisition	-	4,336 Added 13.86%	26,957 Common Stock
May 21 2024	BUY Grant, award, or other acquisition	-	4,410 Added 16.31%	22,621 Common Stock
May 16 2024	SELL Open market or private sale	$127,740 $63.87 p/Share	2,000 Reduced 9.9%	18,211 Common Stock
May 23 2023	BUY Grant, award, or other acquisition	-	6,865 Added 25.35%	20,211 Common Stock
Mar 19 2022	BUY Grant, award, or other acquisition	-	13,346 Added 50.0%	13,346 Common Stock

Also insider at

ZGNX

ZOGENIX, INC.

Director

CRDF

Cardiff Oncology, Inc. Healthcare

RPT